Clinical trials
Noncommunicable Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 8 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 13 |
| 2024 | 17 |
| 2025 | 10 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Recruiting | 15 |
| Unknown status | 11 |
| Not yet recruiting | 6 |
| Active, not recruiting | 6 |
| Enrolling by invitation | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johns Hopkins Bloomberg School of Public Health | 11 |
| Chinese University of Hong Kong | 4 |
| Possible | 3 |
| University of Aarhus | 3 |
| University of North Carolina, Chapel Hill | 3 |
| BRAC University | 2 |
| Chulalongkorn University | 2 |
| Fundacion Universitaria Maria Cano | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| Ottawa Hospital Research Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Noncommunicable Diseases | 95 |
| Diabetes Mellitus | 16 |
| Hypertension | 14 |
| Obesity | 12 |
| Cardiovascular Diseases | 9 |
| Diabetes Mellitus, Type 2 | 6 |
| Overweight | 5 |
| Chronic Disease | 4 |
| Stroke | 4 |
| Asthma | 3 |
Trials
Showing 26 to 50 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.